Àΰø¼öÁ¤ ¼¼°è ½ÃÀå, 2030³â±îÁö 46¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2024³â¿¡ 30¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Àΰø¼öÁ¤ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 7.2%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2030³â¿¡´Â 46¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Àڱà ³» Àΰø¼öÁ¤Àº CAGR 7.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 28¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àڱà ³» Àΰø¼öÁ¤ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.0%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀå 8¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.7%·Î ¼ºÀå Àü¸Á
¹Ì±¹ÀÇ Àΰø¼öÁ¤ ½ÃÀåÀº 2024³â 8¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7¾ï 3,400¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGRÀº 6.7%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.0%¿Í 5.8%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR 5.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è Àΰø¼öÁ¤ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®
Àΰø¼öÁ¤ÀÌ ºÒÀÓ Ä¡·á¿¡¼ Áß¿äÇÑ ¼±ÅÃÀÌ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?
Àΰø¼öÁ¤(AI)Àº ´Ù¸¥ º¸Á¶»ý½Ä¼ú¿¡ ºñÇØ ´ú ħ½ÀÀûÀ̰í, ´Ù¸¥ º¸Á¶»ý½Ä¼ú¿¡ ºñÇØ ´õ Àú·ÅÇÑ ºñ¿ëÀ¸·Î ºÒÀÓ ¹®Á¦¸¦ °Þ°í ÀÖ´Â Ä¿Çðú °³Àο¡°Ô ¸Å¿ì Áß¿äÇÑ ´ë¾ÈÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ¿©¼ºÀÇ ÀÚ±Ã, ÀڱðæºÎ, ³°ü¿¡ Á¤ÀÚ¸¦ Á÷Á¢ ÁÖÀÔÇÏ¿© ¼öÁ¤ °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù. ü¿Ü¼öÁ¤(IVF)°ú °°Àº º¹ÀâÇÑ Ä¡·á¿¡ ºñÇØ AI´Â °£´ÜÇϰí ÀÌ¿ëÇϱ⠽¬¿ö ÀÚ¿¬ ÀÓ½ÅÀÌ ¾î·Á¿î »ç¶÷µé¿¡°Ô Àαâ ÀÖ´Â Ä¡·á¹ýÀ¸·Î, °æ¹ÌÇÑ ³²¼º ºÒÀÓ, ¿øÀÎ ºÒ¸íÀÇ ºÒÀÓ, Á¤ÀÚÀÇ À̵¿¼ºÀ» ¹æÇØÇÏ´Â ÀڱðæºÎ Á¡¾× ¹®Á¦°¡ ÀÖ´Â °æ¿ì¿¡ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. ¶ÇÇÑ AI´Â µ¿¼º Ä¿ÇÃÀ̳ª µ¶½Å ¿©¼º, Á¤ÀÚ ±âÁõÀ» ¿øÇÏ´Â »ç¶÷µé¿¡°Ôµµ ÇʼöÀûÀÎ ¹æ¹ýÀÔ´Ï´Ù. Ãâ»ê Áö¿¬°ú ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ºÒÀÓÀ²ÀÌ Áõ°¡ÇÏ´Â °¡¿îµ¥, Àΰø¼öÁ¤Àº °³Àΰú ºÎºÎ°¡ °¡Á· Çü¼ºÀÇ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀº Àΰø¼öÁ¤ÀÇ ¼º°ø·üÀ» ¾î¶»°Ô ³ôÀ̰í Àִ°¡?
±â¼úÀÇ ¹ßÀüÀº Àΰø¼öÁ¤ÀÇ È¿°ú¿Í ¼º°ø·üÀ» Å©°Ô Çâ»ó½ÃÄÑ ºÒÀÓ Ä¡·á¸¦ ¿øÇÏ´Â »ç¶÷µé¿¡°Ô ´õ¿í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù. ÷´Ü Á¤ÀÚ ¼±º° ¹æ¹ýÀÇ »ç¿ë°ú Á¤ÀÚ º¸Á¸ ±â¼úÀÇ °³¹ß µî Á¤ÀÚ ¼±º° ¹× Áغñ ±â¼úÀÇ Çõ½ÅÀ¸·Î AI ¹æ¹ý¿¡ »ç¿ëµÇ´Â Á¤ÀÚÀÇ Ç°Áú°ú »ýÁ¸À²ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ ½ºÅ©¸®´×°ú ¼±º° °úÁ¤ÀÇ ÅëÇÕÀ¸·Î °¡Àå °Ç°ÇÑ Á¤ÀÚ¸¸ »ç¿ëÇÏ°Ô µÇ¾î Àӽмº°ø °¡´É¼ºÀÌ ´õ¿í ³ô¾ÆÁ³½À´Ï´Ù. ÃÊÀ½ÆÄ À¯µµ Àΰø¼öÁ¤ ±â¼úÀÇ µîÀåÀ¸·Î Á¤ÀÚ ¹èÄ¡ÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾î ¼öÁ¤ °¡´É¼ºÀ» ±Ø´ëÈÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ AI¿Í ±â°è ÇнÀÀ» ÅëÇÑ È¯ÀÚ µ¥ÀÌÅÍ ºÐ¼® ¹× Ä¡·á °á°ú ¿¹ÃøÀ» ÅëÇØ ºÒÀÓ Àü¹®Àǰ¡ º¸´Ù È¿°úÀûÀ¸·Î Ä¡·á¸¦ Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾î AI¸¦ ÅëÇÑ Àü¹ÝÀûÀÎ ¼º°ø·üÀ» ³ôÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ºÒÀÓÀ¸·Î ¾î·Á¿òÀ» °Þ°í ÀÖ´Â ¸¹Àº °³Àΰú ºÎºÎ°¡ AI¸¦ ù ¹øÂ° ¼±Åà ġ·á¹ýÀ¸·Î äÅÃÇÏ´Â °ÍÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Àü ¼¼°èÀûÀ¸·Î Àΰø¼öÁ¤ÀÇ Ã¤ÅÃÀ» Çü¼ºÇÏ´Â Ãß¼¼´Â ¹«¾ùÀΰ¡?
»ý½Ä ÀÇ·á ºÐ¾ßÀÇ ±¤¹üÀ§ÇÑ »çȸÀû º¯È¿Í Áøº¸¸¦ ¹Ý¿µÇÏ¿© ¸î °¡Áö Áß¿äÇÑ Æ®·»µå°¡ Àΰø¼öÁ¤ÀÇ ¼¼°è µµÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Á÷¾÷ÀÇ ¿ì¼±¼øÀ§¿Í ¶óÀÌÇÁ½ºÅ¸ÀÏ ¼±ÅÃÀ¸·Î ÀÎÇØ ºÎ¸ð°¡ µÇ´Â ½Ã±â¸¦ ´ÊÃß´Â °æÇâÀÌ °ÈµÇ¸é¼ AI¸¦ Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¶½ÅÀ̳ª µ¿¼º Ä¿ÇÃÀÌ °¡Á¤À» ²Ù¸®´Â °ÍÀÌ »çȸÀûÀ¸·Î ¹Þ¾Æµé¿©Áö¸é¼ ±âÁõÀÚ Á¤ÀÚ ¼ºñ½º³ª AI ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á °ü±¤µµ Áß¿äÇÑ Æ®·»µåÀ̸ç, ¸¹Àº °³Àΰú Ä¿ÇõéÀÌ AI¸¦ Æ÷ÇÔÇÑ ºÒÀÓ Ä¡·á¸¦ º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö Àְųª Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ±¹°¡·Î ¿©ÇàÀ» ¶°³ª°í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼ÀÇ ºÒÀÓ Ä¡·á Ŭ¸®´ÐÀÇ È®´ëµµ AIÀÇ ¼¼°è ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ª¿¡¼´Â »ý½Ä ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ºÒÀÓ Ä¡·á¿¡¼ ¿ø°ÝÀÇ·áÀÇ ÅëÇÕÀº AI¸¦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé¾î ȯÀÚ°¡ ¿ø°ÝÀ¸·Î Áø·á¸¦ ¹Þ°í Ä¡·á °úÁ¤À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á AI ¼ºñ½ºÀÇ µµ´Þ ¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.
Àΰø¼öÁ¤ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
Àΰø¼öÁ¤ ½ÃÀåÀÇ ¼ºÀåÀº ºÒÀÓ Ä¡·áÀÇ »óȲÀ» º¯È½Ã۰í ÀÖ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È, ȯ°æÀû ¿äÀÎ, Ãâ»ê Áö¿¬°ú °°Àº Æ®·»µå¿¡ ¿µÇâÀ» ¹ÞÀº Àü ¼¼°è ºÒÀÓ·üÀÇ Áõ°¡¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀü, ƯÈ÷ Á¤ÀÚ º¸Á¸, À¯ÀüÀÚ °Ë»ç, AI¸¦ ÅëÇÑ È¯ÀÚ °ü¸® µî AI ¼ö¼úÀÇ ¼º°ø·üÀ» ³ôÀÌ°í ´õ ¸¹Àº ȯÀڵ鿡°Ô ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖ´Â ±â¼ú ¹ßÀüÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. AI¿¡ ´ëÇÑ Àνİú Á¢±Ù¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÅÈï ½ÃÀå¿¡¼ ºÒÀÓ Ä¡·á ¼ºñ½ºÀÇ °¡¿ë¼ºÀÌ È®´ëµÇ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¼º Ä¿ÇÃ, ¹ÌÈ¥¸ð, ±âÁõÀÚ Á¤ÀÚ¸¦ ã´Â °³ÀεéÀÇ ¼ö¿ä°¡ Áõ°¡ÇÏ¸é¼ AIÀÇ ´ëÀÀ °¡´ÉÇÑ ½ÃÀåÀÌ Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÒÀÓ Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤ºÎ ±ÔÁ¦¿Í º¸Çè Àû¿ëÀº AIÀÇ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, AI´Â ¸¹Àº »ç¶÷µé¿¡°Ô º¸´Ù Çö½ÇÀûÀ̰í Á¢±ÙÇϱ⠽¬¿î ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó Àΰø¼öÁ¤ ½ÃÀåÀº ±â¼ú Çõ½Å, »çȸÀû º¯È, Á¢±Ù¼º ³ôÀº ºÒÀÓ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖ´Â ¿©°ÇÀÌ Á¶¼ºµÇ°í ÀÖ½À´Ï´Ù.
ºÎ¹®
À¯Çü(Àڱó», Àڱðæ°ü³», Áú³», ³°ü³»), °ø±Þ¿ø À¯Çü(AIH-ºÎºÎ, AID-±âºÎÀÚ), ÃÖÁ¾ ¿ëµµ(ºÒÀÓÄ¡·á¼¾ÅÍ, º´¿ø ¹× Ŭ¸®´Ð, ±âŸ ÃÖÁ¾ ¿ëµµ)
Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 41°³»ç ÁÖ¸ñ)
- Genea Limited
- Hi-Tech Solutions
- Irvine Scientific
- KITAZATO CORPORATION
- Pride Angel Ltd.
- Rinovum Women's Health, LLC.
- Rocket Medical PLC
- Vitrolife AB
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ¼ºÀå ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ±âŸ Áö¿ª
Á¦4Àå °æÀï
ksm
Global Artificial Insemination Market to Reach US$4.6 Billion by 2030
The global market for Artificial Insemination estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Intracervical Insemination segment is estimated at 7.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$840.0 Million While China is Forecast to Grow at 6.7% CAGR
The Artificial Insemination market in the U.S. is estimated at US$840.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$703.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
Global Artificial Insemination Market - Key Trends and Drivers Summarized
Why Is Artificial Insemination Becoming a Crucial Option in Fertility Treatments?
Artificial insemination (AI) has emerged as a pivotal option for couples and individuals facing infertility issues, offering a less invasive and often more affordable alternative to other assisted reproductive technologies. This procedure involves directly introducing sperm into a woman's uterus, cervix, or fallopian tubes, thereby increasing the likelihood of fertilization. The simplicity and accessibility of AI, compared to more complex treatments like in vitro fertilization (IVF), have made it a popular choice for those experiencing difficulties conceiving naturally. AI is particularly beneficial in cases of mild male infertility, unexplained infertility, or cervical mucus issues that impede sperm mobility. Additionally, AI is an essential method for same-sex couples, single women, and those who opt for donor sperm. As infertility rates rise globally due to factors such as delayed childbearing and lifestyle changes, artificial insemination continues to play a vital role in helping individuals and couples achieve their family-building goals.
How Are Technological Advances Enhancing the Success Rates of Artificial Insemination?
Technological advancements have significantly enhanced the effectiveness and success rates of artificial insemination, making it a more reliable option for those seeking fertility treatment. Innovations in sperm selection and preparation techniques, such as the use of advanced sperm sorting methods and the development of sperm preservation technologies, have improved the quality and viability of sperm used in AI procedures. Additionally, the integration of genetic screening and selection processes ensures that only the healthiest sperm are used, further increasing the chances of successful conception. The advent of ultrasound-guided insemination techniques has also improved the precision of sperm placement, maximizing the likelihood of fertilization. Moreover, the use of AI and machine learning in analyzing patient data and predicting outcomes has allowed fertility specialists to tailor treatments more effectively, improving the overall success rates of AI. These technological advancements are driving the adoption of AI as a first-line treatment for many individuals and couples experiencing fertility challenges.
What Trends Are Shaping the Adoption of Artificial Insemination Worldwide?
Several key trends are influencing the adoption of artificial insemination globally, reflecting broader societal changes and advancements in reproductive healthcare. The increasing trend towards delayed parenthood, driven by career priorities and lifestyle choices, has led to a growing need for fertility treatments, including AI. Additionally, the rising social acceptance of single parenthood and same-sex couples seeking to start families has expanded the demand for donor sperm services and AI procedures. Medical tourism is another significant trend, with many individuals and couples traveling to countries where fertility treatments, including AI, are more accessible or affordable. The expansion of fertility clinics in emerging markets is also contributing to the global growth of AI, as these regions invest in advanced healthcare infrastructure to meet the rising demand for reproductive services. Furthermore, the integration of telemedicine in fertility care has made AI more accessible, allowing patients to receive consultations and monitor their treatment progress remotely, thereby broadening the reach of AI services.
What Factors Are Driving the Growth of the Artificial Insemination Market?
The growth in the artificial insemination market is driven by several factors that are reshaping the landscape of fertility treatment. A major driver is the increasing infertility rates worldwide, influenced by factors such as lifestyle changes, environmental factors, and the trend of delayed childbearing. Technological advancements, particularly in sperm preservation, genetic screening, and AI-driven patient management, are enhancing the success rates of AI procedures, making them more appealing to a broader range of patients. The expanding availability of fertility services in emerging markets, coupled with growing awareness and accessibility of AI, is also propelling market growth. Additionally, the rising demand from same-sex couples, single parents, and individuals seeking donor sperm has significantly expanded the addressable market for AI. Government regulations and insurance coverage that support fertility treatments further drive adoption, making AI a more viable and accessible option for many. As these trends continue to evolve, the artificial insemination market is poised for sustained growth, driven by innovation, societal shifts, and increasing demand for accessible fertility solutions.
SCOPE OF STUDY:
The report analyzes the Artificial Insemination market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Intrauterine, Intracervical, Intravaginal, Intratubal); Source Type (AIH-Husband, AID-Donor); End-Use (Fertility Centers, Hospitals & Clinics, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 41 Featured) -
- Genea Limited
- Hi-Tech Solutions
- Irvine Scientific
- KITAZATO CORPORATION
- Pride Angel Ltd.
- Rinovum Women's Health, LLC.
- Rocket Medical PLC
- Vitrolife AB
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Artificial Insemination - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- Global Economic Update
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Infertility Rates Propel Growth in Artificial Insemination Services
- Advancements in Sperm Preservation and Handling Strengthen Business Case for Artificial Insemination
- Increasing Acceptance of Assisted Reproductive Technologies Expands Addressable Market
- Shift Towards Delayed Parenthood Spurs Demand for Fertility Treatments
- Innovations in Genetic Screening and Selection Enhance Success Rates
- Expansion of Fertility Clinics in Emerging Markets Generates New Opportunities
- Rising Demand for Sperm Banks and Donor Services Expands Market
- Increasing Medical Tourism for Fertility Treatments Propels Market Expansion
- Rising Single Parenthood and Same-Sex Couples Seeking Reproductive Assistance Propel Market Growth
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Artificial Insemination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
- TABLE 4: World Artificial Insemination Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Intrauterine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Intrauterine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Intrauterine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Intracervical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Intracervical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Intracervical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Intravaginal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Intravaginal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Intravaginal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Intratubal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Intratubal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Intratubal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for AIH-Husband by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for AIH-Husband by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for AIH-Husband by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for AID-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for AID-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for AID-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Fertility Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Fertility Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: World 15-Year Perspective for Fertility Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: USA 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: USA 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- CANADA
- TABLE 41: Canada Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: Canada 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Canada 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- JAPAN
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Japan 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Japan 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- CHINA
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: China Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: China 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: China Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: China 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- EUROPE
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Artificial Insemination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Europe 15-Year Perspective for Artificial Insemination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- FRANCE
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 80: France Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: France Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: France 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: France Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: France 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- GERMANY
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 89: Germany Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Germany 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Germany 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- ITALY
- TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Italy 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Italy 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 107: UK Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: UK 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: UK 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Rest of Europe Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: Rest of Europe 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: Rest of Europe Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: Rest of Europe 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Rest of Europe Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Rest of Europe 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Artificial Insemination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Asia-Pacific Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Asia-Pacific 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Asia-Pacific Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Asia-Pacific 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Asia-Pacific Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Asia-Pacific 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF WORLD
- TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Rest of World Historic Review for Artificial Insemination by Type - Intrauterine, Intracervical, Intravaginal and Intratubal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Rest of World 15-Year Perspective for Artificial Insemination by Type - Percentage Breakdown of Value Sales for Intrauterine, Intracervical, Intravaginal and Intratubal for the Years 2015, 2025 & 2030
- TABLE 137: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by Source Type - AIH-Husband and AID-Donor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Rest of World Historic Review for Artificial Insemination by Source Type - AIH-Husband and AID-Donor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Rest of World 15-Year Perspective for Artificial Insemination by Source Type - Percentage Breakdown of Value Sales for AIH-Husband and AID-Donor for the Years 2015, 2025 & 2030
- TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of World Historic Review for Artificial Insemination by End-Use - Fertility Centers, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of World 15-Year Perspective for Artificial Insemination by End-Use - Percentage Breakdown of Value Sales for Fertility Centers, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
IV. COMPETITION